Market by Product, Application, Source Type, and Geography | Forecast 2021-2028
Triton Market Research’s report on the global biosurgery market denotes that based on value, the market is anticipated to surge at a CAGR of 6.21% during the forecasting years 2021-2028. In 2020, the market acquired revenue worth $8516.6 million, and is predicted to reap $15390.1 million by 2028.
Biosurgical products are
innovative solutions that treat complex surgical conditions, prevent excessive
blood loss, and offer wound sealing. These factors have increased the demand
for biological products for application in critical and expensive surgeries.
Factors such as the rising
number of surgical procedures and technological advancements are driving the
growth of the studied market. Besides, the increasing geriatric population is
likely to boost the development of the biosurgery market. For instance, more
than 80% of fractures in people above 50 years are caused by osteoporosis.
Here, the bone density diminishes after 30 years, thereby resulting in bones
breaking easily.
Triton’s report aims to get
an overview of the biosurgery market in terms of various factors. Within this
report, the key insight and the market summary regarding the biosurgery market
have been discussed. Also, the Impact of COVID-19 on the global market,
Porter’s five forces model, trends in biosurgery technology, market
attractiveness matrix, vendor scorecard, and key insights have been studied in
detail.
Furthermore, the innovations
in healthcare facilities, the surge in surgical treatments for musculoskeletal
disorders, the prevalence of spinal fusion and joint reconstruction, and the
strong focus on R&D are other key factors supplementing the studied
market’s progress. Additionally, the development of policies for reimbursement
and compensation is generating new opportunities for the market to leverage to
reach its expected growth.
However, several restraints, such as the high cost of surgeries, complications related to immune response, and the use of minimally invasive surgeries, obstruct the global market’s growth.
Major geographies covered in the biosurgery
market are:
• North America: Canada and United States
• Asia-Pacific: Australia & New Zealand, Japan, India,
ASEAN countries, South Korea, China, and Rest of Asia-Pacific
• Europe: Russia, Spain, United Kingdom, Germany, France,
Italy, and Rest of Europe
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey,
Saudi Arabia, South Africa, and Rest of Middle East & Africa
The segmentation analysis of the biosurgery
market includes:
• Market by Product:
o Hemostatic
Agents
o Bone-Graft
Substitutes
• Synthetic Graft Extenders
• Demineralized Bone Matrix
• Bone Morphogenetic Proteins
• Cell-Based Matrices
o Surgical
Sealing Agents
• Natural
• Synthetic
o Soft-Tissue
Management
• Natural Mesh/Patch
• Synthetic
Mesh/Patch
o Anti-Adhesive
Agents
o Staple
Line Reinforcement
• Market by Application:
o Orthopedic
Surgery
o Cardio
and Thoracic Surgery
o Neuro
and Spine Surgery
o General
Surgery
o Other
Applications
• Market by Source Type:
o Natural
o Synthetic
The renowned companies
thriving in the biosurgery market include Medtronic Plc, Zimmer Biomet Holdings
Inc, Baxter International Inc, Ethicon Inc (Johnson & Johnson), Stryker
Corporation, Becton, Dickinson and Company, RTI Surgical, B Braun Melsungen AG,
Integra Lifesciences Holdings Corporation, Sanofi, Wright Medical Group NV, CSL
Limited, and Smith & Nephew Plc.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
BIOSURGERY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON BIOSURGERY MARKET
2.2. TRENDS
IN BIOSURGERY TECHNOLOGY
2.3. KEY
INSIGHTS
2.4. PORTER’S
FIVE FORCES MODEL
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE PRODUCTS
2.4.3. BARGAINING
POWER OF BUYERS
2.4.4. BARGAINING
POWER OF SUPPLIERS
2.4.5. COMPETITIVE
RIVALRY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
BUYING OUTLOOK
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGING POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES
2.9.3. SURGE
IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.9.4. PREVALENCE
OF SPINAL FUSION AND JOINT RECONSTRUCTION
2.9.5. STRONG
FOCUS ON RESEARCH AND DEVELOPMENT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SURGERIES
2.10.2. COMPLICATIONS
RELATED TO IMMUNE RESPONSE
2.10.3. USAGE
OF MINIMALLY INVASIVE SURGERIES
2.11. MARKET
OPPORTUNITIES
2.11.1. RESEARCH
AND INVESTMENTS IN BIOENGINEERING
2.11.2. DEVELOPMENT
OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. GLOBAL
BIOSURGERY MARKET - BY PRODUCT
3.1. HEMOSTATIC
AGENTS
3.2. BONE-GRAFT
SUBSTITUTES
3.2.1. SYNTHETIC
GRAFT EXTENDERS
3.2.2. DEMINERALIZED
BONE MATRIX
3.2.3. BONE
MORPHOGENETIC PROTEINS
3.2.4. CELL-BASED
MATRICES
3.3. SURGICAL
SEALING AGENTS
3.3.1. NATURAL
3.3.2. SYNTHETIC
3.4. SOFT-TISSUE
MANAGEMENT
3.4.1. SYNTHETIC
MESH/PATCH
3.4.2. NATURAL
MESH/PATCH
3.5. ANTI-ADHESIVE
AGENTS
3.6. STAPLE
LINE REINFORCEMENT
4. GLOBAL
BIOSURGERY MARKET - BY APPLICATION
4.1. ORTHOPEDIC
SURGERY
4.2. CARDIO
AND THORACIC SURGERY
4.3. NEURO
AND SPINE SURGERY
4.4. GENERAL
SURGERY
4.5. OTHER
APPLICATIONS
5. GLOBAL
BIOSURGERY MARKET - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. GLOBAL
BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCT
6.1.1.1. BONE-GRAFT
SUBSTITUTES MARKET BY TYPE
6.1.1.2. SURGICAL
SEALING AGENTS MARKET BY TYPE
6.1.1.3. SOFT-TISSUE
MANAGEMENT MARKET BY TYPE
6.1.2. MARKET
BY APPLICATION
6.1.3. MARKET
BY SOURCE TYPE
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY PRODUCT
6.2.1.1. BONE-GRAFT
SUBSTITUTES MARKET BY TYPE
6.2.1.2. SURGICAL
SEALING AGENTS MARKET BY TYPE
6.2.1.3. SOFT-TISSUE
MANAGEMENT MARKET BY TYPE
6.2.2. MARKET
BY APPLICATION
6.2.3. MARKET
BY SOURCE TYPE
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. GERMANY
6.2.4.2. UNITED
KINGDOM
6.2.4.3. FRANCE
6.2.4.4. ITALY
6.2.4.5. SPAIN
6.2.4.6. RUSSIA
6.2.4.7. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCT
6.3.1.1. BONE-GRAFT
SUBSTITUTES MARKET BY TYPE
6.3.1.2. SURGICAL
SEALING AGENTS MARKET BY TYPE
6.3.1.3. SOFT-TISSUE
MANAGEMENT MARKET BY TYPE
6.3.2. MARKET
BY APPLICATION
6.3.3. MARKET
BY SOURCE TYPE
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. AUSTRALIA
& NEW ZEALAND
6.3.4.5. SOUTH
KOREA
6.3.4.6. ASEAN
COUNTRIES
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCT
6.4.1.1. BONE-GRAFT
SUBSTITUTES MARKET BY TYPE
6.4.1.2. SURGICAL
SEALING AGENTS MARKET BY TYPE
6.4.1.3. SOFT-TISSUE
MANAGEMENT MARKET BY TYPE
6.4.2. MARKET
BY APPLICATION
6.4.3. MARKET
BY SOURCE TYPE
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCT
6.5.1.1. BONE-GRAFT
SUBSTITUTES MARKET BY TYPE
6.5.1.2. SURGICAL
SEALING AGENTS MARKET BY TYPE
6.5.1.3. SOFT-TISSUE
MANAGEMENT MARKET BY TYPE
6.5.2. MARKET
BY APPLICATION
6.5.3. MARKET
BY SOURCE TYPE
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. SAUDI
ARABIA
6.5.4.2. UNITED
ARAB EMIRATES
6.5.4.3. TURKEY
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.2. BECTON,
DICKINSON AND COMPANY
7.3. B
BRAUN MELSUNGEN AG
7.4. CSL
LIMITED
7.5. ETHICON
INC (JOHNSON & JOHNSON)
7.6. INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
7.7. MEDTRONIC
PLC
7.8. RTI
SURGICAL
7.9. SANOFI
7.10. SMITH
& NEPHEW PLC
7.11. STRYKER
CORPORATION
7.12. WRIGHT
MEDICAL GROUP NV
7.13. ZIMMER
BIOMET HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL BIOSURGERY
MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS,
ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 7: AGING POPULATION
AROUND THE WORLD 2019 & 2050
TABLE 8: GLOBAL BIOSURGERY
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL BONE-GRAFT
SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL SOFT-TISSUE
MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL BIOSURGERY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL BIOSURGERY
MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL BIOSURGERY
MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE BIOSURGERY
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 23: EUROPE BIOSURGERY
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 24: EUROPE BONE-GRAFT
SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25: EUROPE SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 26: EUROPE SOFT-TISSUE
MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 27: EUROPE BIOSURGERY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 28: EUROPE BIOSURGERY
MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA SURGICAL
SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND AFRICA
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND AFRICA
SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND AFRICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND AFRICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: GLOBAL BIOSURGERY
MARKET, BY PRODUCT, 2020 & 2028 (IN%)
FIGURE 3: GLOBAL BIOSURGERY
MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL BIOSURGERY
MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL BONE-GRAFT
SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL BONE-GRAFT
SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL BONE-GRAFT
SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL BONE-GRAFT
SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL BIOSURGERY
MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SURGICAL SEALING
AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL SURGICAL SEALING
AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL BIOSURGERY
MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SOFT-TISSUE
MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL SOFT-TISSUE
MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BIOSURGERY
MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL BIOSURGERY
MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL BIOSURGERY
MARKET, BY APPLICATION, 2020 & 2028 (IN%)
FIGURE 18: GLOBAL BIOSURGERY
MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BIOSURGERY
MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL BIOSURGERY
MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL BIOSURGERY
MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL BIOSURGERY MARKET,
BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL BIOSURGERY
MARKET, BY SOURCE TYPE, 2020 & 2028 (IN%)
FIGURE 24: GLOBAL BIOSURGERY
MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL BIOSURGERY
MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 26: UNITED STATES
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: CANADA BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 28: GERMANY BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: UNITED KINGDOM
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: FRANCE BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 31: ITALY BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 32: SPAIN BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 33: RUSSIA BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 34: REST OF EUROPE
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: CHINA BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 36: JAPAN BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 37: INDIA BIOSURGERY MARKET 2021-2028
(IN $ MILLION)
FIGURE 38: AUSTRALIA & NEW
ZEALAND BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: SOUTH KOREA BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: ASEAN COUNTRIES
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: REST OF ASIA-PACIFIC BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: BRAZIL BIOSURGERY MARKET
2021-2028 ($ MILLION)
FIGURE 43: MEXICO BIOSURGERY MARKET
2021-2028 ($ MILLION)
FIGURE 44: REST OF LATIN AMERICA
BIOSURGERY MARKET 2021-2028 ($ MILLION)
FIGURE 45: SAUDI ARABIA BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: UNITED ARAB EMIRATES
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: TURKEY BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 48: SOUTH AFRICA BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 49: REST OF MIDDLE EAST
& AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)